Literature DB >> 12854181

In vitro assay for HCV serine proteinase expressed in insect cells.

Li-Hua Hou1, Gui-Xin Du, Rong-Bin Guan, Yi-Gang Tong, Hai-Tao Wang.   

Abstract

AIM: To produce the recombinant NS3 protease of hepatitis C virus with enzymatic activity in insect cells.
METHODS: The gene of HCV serine proteinase domain which encodes 181 amino acids was inserted into pFastBacHTc and the recombinant plasmid pFBCNS3N was transformed into DH10Bac competent cells for transposition. After the recombinant bacmids had been determined to be correct by both blue-white colonies and PCR analysis, the isolated bacmid DNAs were transfected into Sf9 insect cells. The bacmids DNA was verified to replicate in insect cells and packaged into baculovirus particles via PCR and electronic microscopic analysis. The insect cells infected with recombinant baculovirus were determined by SDS-PAGE and Western-blot assays. The recombinant protein was soluted in N-lauryl sarcosine sodium (NLS) and purified by metal-chelated-affinity chromatography, then the antigenicity of recombinant protease was determined by enzyme-linked immunoabsorbant assay and its enzymatic activity was detected.
RESULTS: The HCV NS3 protease domain was expressed in insect cells at high level and it was partially solved in NLS. Totally 0.2 mg recombinant serine proteinase domain with high purity was obtained by metal-chelated-affinity chromatography from 5 x 10(7) cells, and both antigenicity and specificity of the protein were evaluated to be high when used as antigen to detect hepatitis C patients' sera in indirect ELISA format. In vitro cleavage assay corroborated its enzymatic activity.
CONCLUSION: The recombinant HCV NS3 proteinase expressed by insect cells is a membrane-binding protein with good antigenicity and enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854181      PMCID: PMC4615522          DOI: 10.3748/wjg.v9.i7.1629

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

Review 1.  Replication of hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

2.  Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions.

Authors:  H Okamoto; S Okada; Y Sugiyama; K Kurai; H Iizuka; A Machida; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

Review 3.  Baculovirus systems for the expression of human gene products.

Authors:  V A Luckow
Journal:  Curr Opin Biotechnol       Date:  1993-10       Impact factor: 9.740

4.  Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease.

Authors:  Gui-Xin Du; Li-Hua Hou; Rong-Bin Guan; Yi-Gang Tong; Hai-Tao Wang
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Internal processing of hepatitis C virus NS3 protein.

Authors:  I Shoji; T Suzuki; M Sato; H Aizaki; T Chiba; Y Matsuura; T Miyamura
Journal:  Virology       Date:  1999-02-15       Impact factor: 3.616

6.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli.

Authors:  V A Luckow; S C Lee; G F Barry; P O Olins
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

9.  Expression and identification of hepatitis C virus polyprotein cleavage products.

Authors:  A Grakoui; C Wychowski; C Lin; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  A novel high throughput screening assay for HCV NS3 serine protease inhibitors.

Authors:  Yevgeny Berdichevsky; Romy Zemel; Larisa Bachmatov; Alex Abramovich; Ruth Koren; Peramachi Sathiyamoorthy; Avi Golan-Goldhirsh; Ran Tur-Kaspa; Itai Benhar
Journal:  J Virol Methods       Date:  2003-02       Impact factor: 2.014

View more
  2 in total

1.  A rapid and efficient method to express target genes in mammalian cells by baculovirus.

Authors:  Tong Cheng; Chen-Yu Xu; Ying-Bin Wang; Min Chen; Ting Wu; Jun Zhang; Ning-Shao Xia
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

2.  Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses.

Authors:  Bingke Bai; Xinya Lu; Jin Meng; Qinxue Hu; Panyong Mao; Baojing Lu; Ze Chen; Zhiming Yuan; Hanzhong Wang
Journal:  Mol Immunol       Date:  2007-10-01       Impact factor: 4.407

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.